The American Journal of Managed Care6d
FDA Approves Hercessi, the Sixth Trastuzumab Biosimilar
The recent FDA approval of Hercessi expands access to a treatment previously burdened by high costs. Hercessi joins the 5 ...
centerforbiosimilars6d
FDA Approves Henlius’ Trastuzumab Biosimilar, Hercessi
The approval marks the sixth for a biosimilar referencing Herceptin (trastuzumab) for the treatment of HER2-positive breast ...
Pharm Exec6d
FDA Approves New Herceptin Biosimilar for the Treatment of Multiple HER2-Overexpressing Cancers
Hercessi marks Accord BioPharma’s first biosimilar to be approved in the United States, with multiple indications for ...
InnovationRx: FDA Approves Abbott’s Dissolvable Stents
Autoimmune Disorders: Bristol Myers Squibb has entered into a research agreement with Repertoire to develop vaccines for ...
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
Pfizer Inc. (NYSE: PFE) and Genmab A/S (Nasdaq: GMAB) today announced the U.S. Food and Drug Administration (FDA) approves ...
The American Journal of Managed Care6d
Tisotumab Vedotin Gains Full FDA Approval for Recurrent or Metastatic Cervical Cancer
Tisotumab vedotin is an antibody-drug conjugate ... a cervical cancer patient advocate and founder and Chief Visionary Officer at Cervivor, Inc., commented. 2 1. FDA approves tistumab vedotin ...
Daily4d
FDA approves dissolving stent for endovascular treatment of peripheral artery disease below knee
The US Food and Drug Administration has approved Esprit BTK everolimus-eluting scaffold system for chronic limb-threatening ...
Pharmabiz3d
US FDA approves Abbott's breakthrough dissolving stent, Esprit BTK System for people with CLTI below-the-knee
Abbott Park, Illinois Thursday, May 2, 2024, 15:00 Hrs [IST] ...